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Purpose Obesity can make bone marrow biopsy using manual landmarks as guidance technically challenging. This retrospective review was performed to assess the
safety and technical success of performing bone marrow biopsies with computed
tomography (CT)–guidance in obese patients.
Materials and Methods This single-institution, retrospective study included 1,016
CT-guided bone marrow biopsies performed between 2009 and 2016. Thirty-four percent (n = 348) were performed in patients with a body mass index (BMI) of 30 kg/m2
or greater, and 7% (n = 75) were performed in patients with a BMI greater than 40 kg/
m2. Demographic information, BMI, and complications were reviewed. The primary
endpoint was technical success and procedurally related hemorrhagic complication.
The electronic medical record was reviewed to identify procedural related hemorrhagic complications, Common Terminology Criteria for Adverse Events (CTCAE) Grade 3
or above. The complication rates in obese patients were compared with patients with
a BMI less than 30 kg/m2.
Results Biopsy was successfully performed in all patients. No biopsies resulted in
a CTCAE Grade 3 or above complication. There was no difference in complication
rate (0%) based on BMI. For patients with a BMI < 30 kg/m2, BMI ≥ 30 kg/m2, and
BMI > 40 kg/m2, complications rates were 0% (95% confidence interval [CI]: 0–0.4%),
0% (95% CI: 0–0.9%), and 0% (95% CI: 0–4%), respectively.
Conclusions CT-guided bone marrow biopsy in obese patients can be performed
with a high rate of technical success and is safe. If patient body habitus limits the
ability to palpate physical landmarks needed to perform bone marrow biopsy without
image guidance, CT-guided bone marrow biopsy should be considered.

Introduction
Bone marrow biopsy and aspiration is a commonly performed procedure, used to aid in the diagnosis, monitoring,
and staging of multiple diseases, primarily hematologic or
metastatic in nature. The retrieved specimens provide vital
information regarding the patient’s disease, through the use
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of immunohistochemical stains, cytogenetic analysis, flow
cytometry, and molecular assays.1,2
Overall, bone marrow biopsy is a safe procedure, with
a complication rate of less than 0.1%.3-5 The most common
complication reported is hemorrhage.3,4,6 Obese patients tend
to have higher levels of coagulation factors and lower levels
of tissue plasminogen activator (t-PA) activity,7 and some
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studies have shown increased bleeding in patients undergoing percutaneous coronary intervention with a lower body
mass index (BMI).8 This data suggests that obesity could
potentially protect against bleeding; however, obesity is a
risk factor for hemorrhage after bone marrow biopsy.3,5,6
Excess adipose tissue can make bedside bone marrow biopsies technically challenging due to the loss of physical landmarks used to guide biopsy.9,10
Performing a bedside bone marrow biopsy without palpable physical landmarks risks neurovascular injury if the
needle is advanced into an adjacent tissue compartment

other than the iliac bone. If the gluteal compartment is
entered, there is risk of gluteal artery hemorrhage, pseudoaneurysm, or gluteal compartment syndrome.5,11 If the
needle is advanced too deeply and penetrates the inner iliac
cortex, it can result in iliac and/or pelvic vessel injury and
lead to retroperitoneal hemorrhage.5,11
Use of computed tomography (CT)–guidance has been
proven to be safe and efficacious for liver and renal biopsies in obese patients, with the added benefit of more rapid
identification of complications.11-13 This retrospective review
was performed to test the hypothesis that performing bone
marrow biopsies with CT guidance in obese patients is technically feasible and safe.

Materials and Methods
This institutional review board–approved study was designed
as a retrospective cohort study with the primary endpoint
being the occurrence of Common Terminology Criteria
for Adverse Events (CTCAE) Grade 3 or above hemorrhagic
complication.14 There was a waiver granted for informed
consent, compliant with the Health Insurance Portability and
Accountability Act. The authors have no conflicts of interest
to report.
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(n = 348) of bone marrow biopsies were performed on inpatients with a BMI of 30 kg/m2 or greater.

Biopsy Procedure

Procedural consents were obtained prior to the start of each
procedure. After positioning the patient in the prone position, sedation was administered by either the interventional
radiologist or separate anesthesia staff. Although sedation
information was not assessed in these patients, at the performing institution, sedation is typically performed with a
combination of midazolam, fentanyl, and/or propofol for
these procedures. A limited field of view low-dose CT scan
of the pelvis was then obtained for procedural planning. For
local anesthesia, 2% lidocaine was administered along the
expected needle trajectory, to include the skin and periosteum of the posterior superior iliac crest. A Carefusion AVAmax 11-gauge coaxial biopsy needle system (BD-Carefusion)
was advanced through the cortical bone where an aspirate
and core biopsy was obtained (►Fig. 1). The bone marrow
aspiration was performed by attaching a syringe to the
11-guage access cannula. Subsequently, a single core biopsy
with a 14-guage biopsy needle was performed through the
access cannula. All patients were instructed to lie flat on
their back for 1 hour after the procedure and vital signs were
monitored every 15 minutes during recovery. Nursing staff
was instructed to inform the interventional radiologist if the
patient experienced increased pain or bleeding at the biopsy
site. After 1 hour in recovery, inpatients were transported to
their hospital room and outpatients were allowed to go home
(with a driver).

Patient Selection

A database of bone marrow biopsies performed within our
institution between May 1, 2009, and May 1, 2016, was retrospectively collected with patients identified using Montage
Search and Analytics software (Montage Healthcare Solutions). All patients who underwent CT-guided bone marrow
biopsies were included. Patients who underwent bone marrow biopsy without CT-guidance were excluded along with all
biopsies outside of the approved study time frame. Patients
who did not have weight or height documented within one
month of the biopsy were also excluded. A total of 1,023 bone
marrow biopsies were performed using CT guidance during
the study period; 7 were excluded because weight or height
was not documented. The patients in this study were previously studied to assess the impact of platelet count on risk of
hemorrhagic complication.15 Although the biopsies were performed in a hospital setting, the study population included
both inpatients and outpatients.
Of the final population of 1,016 biopsies, mean age was
57 years (range 15–93 years), 492 patients were female
(48%), and 524 patients were male (52%). Thirty-four percent

Fig. 1 Axial computed tomography (CT) image in bone window
demonstrates a biopsy needle extending into the posterior right iliac
bone, through the use of a lateral approach. Note the prominent subcutaneous tissue, which could potentially limit use of guidance using
anatomic landmarks.
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Assessment of Complications

Each patient’s medical record was reviewed, including the
48 hours following each biopsy to identify CTCAE Grade 3 or
above complications. A Grade 3 arterial injury complication
is defined as any injury that results in severe symptoms and
requires repair or intervention. The electronic medical record
was reviewed for all patients, with attention for any postprocedural imaging demonstrating a biopsy site hematoma, any
hemoglobin drop greater than 2 g/dL following the procedure, or any evidence of sustained hemodynamic instability
requiring initiation of vasopressors. Subjective biopsy site
pain/discomfort without corresponding vital sign instability
or biopsy site bleeding/hematoma was not considered a significant complication.

Statistical Analysis

The hemorrhagic complication rates of the patients were
calculated for patients with normal BMI, BMI of 30 kg/m2
or greater, and BMI greater than 40 kg/m2. The complication
rates for obese patients (BMI ≥ 30 kg/m2 and BMI > 40 kg/m2)
were compared with patients with BMI less than 30 kg/m2.
Two-tailed 95% confidence intervals based on Poisson distribution for complication rate in obese patients were also
calculated. Continuous data are presented as mean and
standard deviation and compared using the unpaired t-test.
Categorical data are presented as percentages and counts and
compared using the chi-square test. SPSS v.22.0.0 (SPSS Inc.)
was used for statistical analysis.

Results
Of the 1,016 patients in the study population, 348 were had a
BMI ≥ 30 kg/m2 and 75 had a BMI > 40 kg/m2. The highest BMI
included in our study population was 66.7 kg/m2. Thirty-seven
percent of the female population was obese, with 8% having
a BMI > 40 kg/m2. Thirty-one percent of the male population
was classified as obese, with 6% having a BMI > 40 kg/m2. This
was not significantly different between groups (p = 0.12).
Demographic information is presented in ►Table 1.
Technical success was achieved in all patients. Out of
1,016 biopsies, 0 resulted in a complication. No interventions
or transfusions were needed for procedure-related bleeding.
There were no instances of clinically symptomatic bleeding
and no imaging was performed for suspicion of bleeding.
There was no difference in rate of hemorrhagic complications (0%) based on BMI (p = 1.0). For patients with BMI less
than 30 kg/m2, the rate for hemorrhagic complications was
0% (95% confidence interval [CI]: 0–0.4%). For patients with

a BMI of 30 kg/m2 or greater, the rate for hemorrhagic complications was 0% (95% CI: 0–0.9%). For patients with a BMI
greater than 40 kg/m2, the rate for hemorrhagic complications was 0% (95% CI: 0–4%).

Discussion
Bone marrow biopsies are indicated for the diagnostic
work-up and monitoring of several disease pathologies,
including malignancy, hematologic abnormalities, and infection. Most frequently the bone marrow aspiration and core
biopsy are performed on the posterior superior iliac crest.16
This is in part due to the accessibility and ease of identification of the anatomic landmarks, lack of large overlying vessels or nerves, as well as the characteristically delayed loss of
cellularity of the axial skeleton. However, in obese patients,
identification of the anatomic landmarks by physical exam
can be unreliable, and in this setting, imaging guidance via
the use of CT is helpful.17 CT-guided bone marrow biopsy
was technically successful in all of the obese patients, but,
to the authors knowledge, there is no reported incidence of
the technical success of blinded bone marrow biopsies in this
patient population for comparison.
Although bone marrow aspiration and core biopsy is a
low-risk procedure with rare complications, it is not without risk.3,5 One study of blind bone marrow aspiration for
reconstructive orthopedic surgery reported a major complication rate of 0.6% and a minor complication rate of 2%.18
Major complications included hematoma requiring transfusion and gait disturbance for 2 months.18 This study required
large bone marrow aspiration volumes, so the orthopedic
surgeons made multiple passes into the bone through the
same skin incision which may have resulted in a higher
incidence of complication compared with diagnostic (lowvolume) bone marrow aspiration.18 Another study reported
hemorrhage in only 0.07% of patients; however, it was “lifethreatening or contributed to death” in 3 of the 10 patients
who suffered this complication.4 Reported risk factors for
hemorrhagic complication after bone marrow biopsy include
a diagnosis of a myeloproliferative disorder, aspirin therapy,
warfarin 
therapy, disseminated intravascular coagulation
(DIC), thrombocytopenia ranging from 25,000–68,000/µL,
and obesity.3,5 To the authors’ knowledge, no prior study
evaluates complication rate of bone marrow biopsy or aspiration in the obese population. While some make the argument that a highly experienced operator can successfully
perform bone marrow biopsies without anatomic landmarks, others advocate for the use of CT guidance to safely

Table 1 Patient demographic information
Men (n = 524)
BMI <30 kg/m2
BMI: 30–40 kg/m

Women (n = 492)

n

%

n

%

360

69%

308

63%

130

25%

143

29%

BMI >40 kg/m2

34

6%

41

8%

Age (y)

58

15.1

57.4

15.2

2
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perform the procedure. Devaliaf and Tudor were some of the
first to advocate the use of CT guidance for bone marrow
biopsy of hematologic disorders, rather than just for osseous
lesions.9 In response, Ghosh stated that CT-guided biopsy is
rarely needed, unless unguided biopsy fails and an anterior
approach is to be attempted.9,19
Worldwide obesity has tripled since 1975,20 and will likely
lead to increased obesity-related morbidity in medicine. While
bone marrow biopsy complications may not be directly associated with obesity, the inciting factor is often an inability to
determine landmarks and/or needle position.21-26 Performing
bone marrow biopsy under CT guidance eliminates the need
for bony landmarks and should be considered as a safe alternative in these patients.
This study is limited by the retrospective nature of the study,
which lends itself to selection bias. Patients in this cohort are,
by nature, more likely to be sicker than those in whom the
referring physician felt comfortable performing the biopsy at
bedside or in clinic. However, this would further support the
safety of CT-guided bone marrow biopsies in the obese population. Furthermore, this study was not able to assess if the risk
hemorrhagic complication in obese patients is reduced by using
CT guidance because it did not include obese patients who
underwent blind bone marrow biopsy. In addition, restricting
the postprocedure observation period to 48 hours could have
resulted in potentially missing a delayed complication.
This retrospective study demonstrated that CT-guided
bone marrow biopsy in obese patients is performed with
high probability of technical success and is safe. In obese
patients who lack the physical landmarks used to guide bedside bone marrow biopsy, CT guidance should be considered.
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